Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

London, United Kingdom (PressExposure) March 15, 2011 -- The global infectious immunology market is forecast to reach $8.8 billion by 2017, growing at a compoundannual growth rate (CAGR) of 6% during the period 2010-2017. The hepatitis viruses segment grew at7% and was valued at $2 billion in 2010. The retroviruses segment in the same year was valued at $1.7 billion and grew at 7%. Bacteriology and other virology segments grew at 6% and 7% and were valued at$1.2 billion and $893.7m. The global infectious immunology market expects to grow due to the increasingincidence of certain diseases, including viral hepatitis, respiratory syncytial virus (RSV), influenza,tuberculosis, human immunodeficiency virus (HIV) and other sexually transmitted diseases (STDs).

The market is also expected to be driven by increased emphasis on testing for hospital acquired pathogens and the re-emergence of new strains of pathogens, which will lead to the increased use ofrapid tests. Emerging and re-emerging infectious diseases such HIV, severe acute respiratory syndrome(SARS), H5N1 avian influenza, Ebola and Nipah virus have become a cause for concern globally.

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages.aspx?ID=Infectious-Immunology-Reagents-Instruments-and-Test-Kits-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017&Title=Medical_Devices&ReportType=Industry_Report

Emerging markets offer strong growth opportunities for in vitro diagnostics (IVD). The infectious immunology markets in China, Brazil and India are expected to grow at a higher than average rate in 2010-2017, at 17%, 17% and 19% respectively. Emerging markets offer new opportunities for IVD companies who are witnessing slower growth in mature markets such as the US, the European Union (EU) and Japan. The strong growth in emerging countries is primarily driven by rising income levels along with a rising level of healthcare access and funding. The government in these countries is taking a step towards improving healthcare quality and access to the latest medical advancements. High growth in these markets is thus going to drive the growth of the infectious immunology market in the future.

GlobalData's new report, "Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data,information and analysis on the global infectious immunology market. The report provides market landscape, competitive landscape and market trends information on the infectious immunology market.The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Infectious-Immunology-Reagents-Instruments-and-Test-Kits-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017&Title=Medical_Devices&ReportType=Industry_Report

Visit our report store: http://www.globaldata.com

For more details contact:
pressreleases@globaldata.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782

About Globaldata

GlobalData is an industry analysis specialist, providing business information products and services. GlobalData's highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge.

Press Release Source: http://PressExposure.com/PR/Globaldata.html

Press Release Submitted On: March 15, 2011 at 1:20 am
This article has been viewed 32002 time(s).